12.30

0.73% -0.09

Centessa Pharmaceuticals Plc Adr (CNTA)

Overview News Price History Option Chain Financials Discussions Forecast

Centessa Pharmaceuticals Plc Adr stock is traded at $12.30, with a volume of 509.88K. It is down -0.73% in the last 24 hours and up +4.59% over the past month. Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Previous Close:

$12.39

Open:

$12.33

24h Volume:

509.88K

Relative Volume:

0.53

Market Cap:

$1.81B

Revenue:

Net Income/Loss:

$-151.09M

P/E Ratio:

-7.8846

EPS:

-1.56

Net Cash Flow:

$-160.51M

1W Performance:

-9.63%

1M Performance:

+4.59%

6M Performance:

-25.45%

1Y Performance:

+28.80%

1-Day Range:

$12.09

$12.85

1-Week Range:

$11.82

$13.84

52-Week Range:

$7.75

$19.09

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile

Name

Centessa Pharmaceuticals Plc Adr

Sector

Healthcare (1153)

Industry

Biotechnology (676)

Phone

44 7391 789784

Address

3RD FLOOR, ALTRINCHAM, CHESHIRE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CNTA's Discussions on Twitter

Compare CNTA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CNTA Centessa Pharmaceuticals Plc Adr	12.30	1.81B	0	-151.09M	-160.51M	-1.56
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-08-25	Initiated	Chardan Capital Markets	Buy
Mar-31-25	Initiated	Piper Sandler	Overweight
Jan-07-25	Initiated	TD Cowen	Buy
Sep-20-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-19-24	Initiated	B. Riley Securities	Buy
Jul-18-24	Initiated	Oppenheimer	Outperform
Nov-15-23	Upgrade	Jefferies	Hold → Buy
Oct-26-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Jun-21-23	Initiated	Evercore ISI	Outperform
Jun-12-23	Initiated	Guggenheim	Buy
Mar-17-23	Initiated	SVB Securities	Outperform
Aug-12-22	Downgrade	Morgan Stanley	Overweight → Underweight
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-03-22	Downgrade	Jefferies	Buy → Hold
Feb-11-22	Initiated	Goldman	Neutral

View All

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Latest News

01:02 AM

Is Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) A Suitable Stock For New Investors Today? - Stocksregister

01:02 AM

May 07, 2025

Ratios in Focus: Analyzing Centessa Pharmaceuticals plc ADR (CNTA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 07, 2025

May 02, 2025

Investor’s Delight: Centessa Pharmaceuticals plc ADR (CNTA) Closes Weak at 13.50, Down -1.53 - DWinneX

May 02, 2025

May 01, 2025

Was Centessa Pharmaceuticals plc ADR (CNTA)’s session last reading good? - uspostnews.com

May 01, 2025

Apr 24, 2025

Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - Sete News

Apr 24, 2025

Investor’s Toolkit: Key Ratios for Assessing MSCI Inc (MSCI)’s Performance - DWinneX

Apr 24, 2025

Financial Metrics Check: Centessa Pharmaceuticals plc ADR (CNTA)’s Ratios for Trailing Twelve Months - DWinneX

Apr 24, 2025

Apr 23, 2025

Should investors be concerned about Centessa Pharmaceuticals plc ADR (CNTA)? - uspostnews.com

Apr 23, 2025

Apr 10, 2025

Parsons Corp (PSN) Shares Up Despite Recent Market Volatility - News Heater

Apr 10, 2025

Apr 01, 2025

Lantheus Holdings Inc [LNTH] Insider Activity: An Update for Investors - knoxdaily.com

Apr 01, 2025

Mar 31, 2025

Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target - MarketScreener

Mar 31, 2025

Mar 26, 2025

Centessa Pharmaceuticals chief business officer sells $163,386 in stock - Investing.com

Mar 26, 2025

Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 By Investing.com - Investing.com South Africa

Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 - Investing.com India

Mar 21, 2025

Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 By Investing.com - Investing.com South Africa

Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 - Investing.com India

Mar 19, 2025

Centessa Pharmaceuticals’ general counsel sells $98,697 in stock - Investing.com

Mar 19, 2025

Mar 03, 2025

Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register

Mar 03, 2025

Feb 25, 2025

Ratios Revealed: Decoding Centessa Pharmaceuticals plc ADR (CNTA)’s Financial Health - The Dwinnex

Feb 25, 2025

Feb 18, 2025

Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight - GlobeNewswire Inc.

Feb 18, 2025

Feb 11, 2025

Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com India

Feb 11, 2025

Feb 10, 2025

Aegon Ltd (AEG) looking to reclaim success with recent performance - SETE News

Feb 10, 2025

Adversity is less terrifying than hope: Wayfair Inc (W) - SETE News

Feb 10, 2025

Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News

Feb 10, 2025

Taking the lead: Centessa Pharmaceuticals plc ADR (CNTA) - SETE News

Feb 10, 2025

Feb 07, 2025